Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is planned to medicate oral T3(Liothyronine)to the patients who are planned to have OPCAB(off- pump coronary bypass graft surgery. The aim of this study was to assess the effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone concentrations, hemodynamic variables and outcomes in patients undergoing OPCAB in a randomized, controlled trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Can Oral T3 Normalize Thyroid Hormone Levels Following Cardiopulmonary Bypass in Children?

NCT01780584

Low T3 Syndrome

COMPLETED PHASE2

Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass

NCT02320669

Congenital Heart Defects

COMPLETED PHASE3

Oral Triiodothyronine for Infants Less Than 5 Months & Malnourished Children Undergoing Cardiopulmonary Bypass in Indonesia

NCT02222532

Postoperative; Dysfunction Following Cardiac Surgery

COMPLETED PHASE3

Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function

NCT00636584

Nitroprusside Thyroid Hormones

UNKNOWN PHASE4

Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia

NCT02521168

Postoperative; Dysfunction Following Cardiac Surgery

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-thyroidal Illness Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

T3

triiodothyronine

Group Type EXPERIMENTAL

liothyronine sodium

Intervention Type DRUG

liothyronine sodium 20ug, every 12hour (before anesthetic induction, total 4 times)

cyanocobalamin

vitamin B12

Group Type ACTIVE_COMPARATOR

placebo

Intervention Type DRUG

vitamin B12

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

liothyronine sodium

liothyronine sodium 20ug, every 12hour (before anesthetic induction, total 4 times)

Intervention Type DRUG

placebo

vitamin B12

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are undergoing Off-pump coronary artery bypass graft

Exclusion Criteria

* No normal sinus rhythm,
* History of thyroid disease
* Abnormal thyroid hormone
* Renal dysfunction
* Hepatic dysfunction
* LVEF \<30%
* Recent MI
* Active infection 1\~15

Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No